Clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence.
PGxAI has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
PGxAI's investors include Google, Amazon Web Services, ATEM Capital Fund LP, Microsoft, Intersystems.
PGxAI is headquartered in Palo Alto, United States.
Clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence.
PGxAI is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PGxAI — Funding & Investors." VCBacked, September 14, 2026, https://www.vcbacked.co/company/pgxai. Accessed October 30, 2026.
VCBacked. (2026). PGxAI — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/pgxai
{{cite web |title=PGxAI — Funding & Investors |url=https://www.vcbacked.co/company/pgxai |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated